Oragenics, Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on September 16, 2026. The filing serves to disclose a scheduled presentation by the Company's Chief Medical Officer, James P. Kelly, at the IPAC-RS 2026 Nasal Innovation Forum on September 17, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing focuses solely on the announcement of an upcoming industry presentation.
Guidance, Outlook, and Risks
- Event Details: The Chief Medical Officer will present in the "Successful Case Studies" session at the IPAC-RS 2026 Nasal Innovation Forum.
- Disclosure: The presentation materials are attached as Exhibit 99.1 and are available on the Company's website.
- Forward-Looking Statements: The Company undertakes no duty to update or revise the information contained in the presentation unless required by law or as management deems warranted.
- Regulation FD: The filing satisfies Regulation FD disclosure requirements regarding the presentation.
Investor Verification Checklist
- Verify the content of the presentation attached as Exhibit 99.1 for specific clinical data or case study details.
- Review the press release attached as Exhibit 99.2 for additional context on the forum participation.
- Check the "Presentations" tab on the Company's website (www.oragenics.com) for the full slide deck.
- Confirm that no financial updates were issued concurrently with this event announcement.